Keith Raymond Mulholland

This inventor holds 16 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1996-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Raymond Mulholland. Retrieved from https://idiyas.com/inventor/keith-raymond-mulholland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 87.5

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 191(Granted Patents)

Location History:

Essex, GB (1998)
Harlow, GB (1996 - 2007)

Company Filing History:

16 out of 2,198

Smithkline Beecham Corporation

patents

Years Active: 1996-2007

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7232902 - Process to prepare (1-carboxymethyl)-pyrimidinone compounds (2007-06-19),

2. 6638953 - Indole derivatives as 5-HT receptor antagonist (2003-10-28),

3. 6235758 - Indole derivatives as 5-HT receptor antagonist (2001-05-22),

4. 6114329 - 5-HT.sub.4 receptor antagonists useful in the treatment of (2000-09-05),

5. 5990133 - Indole derivatives as 5-HT receptor antagonist (1999-11-23),

6. 5972937 - Heterocyclic compounds possessing 5HT.sub.2C receptor antagonist activity (1999-10-26),

7. 5919932 - Biphenylamide derivatives as 5HT.sub.1D antagonists (1999-07-06),

8. 5905080 - Amide and urea derivatives as 5HT1D receptor antagonists (1999-05-18),

9. 5872134 - 5-HT4 receptor antagonists (1999-02-16),

10. 5786372 - Heteroaryl compounds used as pharmaceuticals (1998-07-28),

11. 5741801 - 5-HT.sub.4 receptor antagonist (1998-04-21),

12. 5726187 - N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring (1998-03-10),

13. 5708174 - Heterocyclic-esters or -amides used as 5-HT.sub.4 receptor antagonists (1998-01-13),

14. 5620992 - Heteroaryl compounds used as pharmaceuticals (1997-04-15),

15. 5580885 - 5-HT.sub.4 receptor antagonists (1996-12-03),

Title: The Innovations of Keith Raymond Mulholland

Introduction: Keith Raymond Mulholland, an accomplished inventor based in Harlow, GB, has made significant contributions to the field of pharmaceuticals with a notable portfolio of 16 patents. His work primarily focuses on innovative compounds and processes that have potential applications in treating various central nervous system disorders.

Latest Patents: Among his latest inventions, Mulholland has developed a process to prepare (1-carboxymethyl)-pyrimidinone compounds, which involves innovative methodologies for synthesizing specific pyrimidinone compounds. In addition, he has also produced indole derivatives as 5-HT receptor antagonists, targeting heterocyclic compounds with pharmacological activity and their applications in treating CNS disorders, including anxiety.

Career Highlights: Keith Mulholland is currently affiliated with SmithKline Beecham Corporation, a company recognized for its contributions to health care and pharmaceuticals. His prolific output and innovative thinking have positioned him as a key player in the development of new therapeutics and compounds.

Collaborations: Throughout his career, Mulholland has collaborated with notable coworkers such as Laramie Mary Gaster and Francis D King. These partnerships have enhanced his work's scope and impact, facilitating the development of groundbreaking pharmaceutical innovations.

Conclusion: Keith Raymond Mulholland exemplifies the spirit of innovation within the pharmaceutical industry. With his impressive number of patents and continued focus on advancements in pharmacological compounds, he is poised to make further significant contributions to medicine and health care in the future.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]